Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapyJames R. Berenson, Robert Vescio, James Hilger et al.|Leukemia|2014Cited by 76
Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone LossJames R. Berenson, Regina A. Swift, Siu‐Fun Wong et al.|Clinical Cancer Research|2008Cited by 70
Phase <scp>I</scp>/<scp>II</scp> trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myelomaJames R. Berenson, Debra Mayo, Ori Yellin et al.|British Journal of Haematology|2012Cited by 53
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R. Berenson, Robert Vescio, James Hilger et al.|Annals of Hematology|2013Cited by 36
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R. Berenson, Regina A. Swift, Ori Yellin et al.|British Journal of Haematology|2011Cited by 31